Advertisement

Topics

GSK links with AI spinout to cut costs and speed drug discovery

07:47 EDT 3 Jul 2017 | thePharmaLetter

In a second deal with a pharma major in as many months, Exscientia, an innovative company at the forefront…

Original Article: GSK links with AI spinout to cut costs and speed drug discovery

NEXT ARTICLE

More From BioPortfolio on "GSK links with AI spinout to cut costs and speed drug discovery"

Advertisement
Quick Search
Advertisement
Advertisement